The Second Affiliated Hospital of Zhengzhou University, 450000 Zhengzhou, Henan, China.
The Fifth Affiliated Hospital of Zhengzhou University, 450000 Zhengzhou, Henan, China.
Heart Surg Forum. 2023 Aug 23;26(4):E363-E371. doi: 10.59958/hsf.5885.
To compare the outcomes of two Thoracic Endovascular Aortic Repair (TEVAR) techniques of Left Subclavian Artery (LSA) reconstruction for Stanford Type B Aortic Dissection (TBAD) patients with undesirable proximal anchoring zone.
We retrospectively reviewed 57 patients with TBAD who underwent either three dimensional (3D)-printing-assisted extracorporeal fenestration (n = 32) or conventional extracorporeal fenestration (n = 25) from December 2021 to January 2023. We compared their demographic characteristics, operative time, technical success rate, complication rate, secondary intervention rate, mortality rate, and aortic remodeling.
Compared with the conventional group, the 3D-printing-assisted group had a significantly shorter operative time (147.84 ± 33.94 min vs. 223.40 ± 65.93 min, p < 0.001), a significantly lower rate of immediate endoleak (3.1% vs. 24%, p = 0.048) and a significantly higher rate of true lumen diameter expansion in the stent-graft segment (all p < 0.05), but a significantly longer stent graft modification time (37.63 ± 2.99 min vs. 28.4 ± 2.12 min, p < 0.001). There were no significant differences in other outcomes between the two groups (p > 0.05). The degree of false lumen thrombosis was higher in the stent-graft segment than in the non-stent-graft segment in both groups and the difference was statistically significant (X2 = 5.390, 4.878; p = 0.02, 0.027).
Both techniques are safe and effective for TBAD with an undesirable proximal landing zone. The 3D-printing-assisted extracorporeal fenestration TEVAR technique has advantages in operative time, endoleak risk, and aortic remodeling, while the traditional extracorporeal fenestration TEVAR technique has advantages in stent modification.
比较两种胸主动脉腔内修复术(TEVAR)治疗 Stanford B 型主动脉夹层(TBAD)伴近端锚定区不理想患者的左锁骨下动脉(LSA)重建技术的结果。
我们回顾性分析了 2021 年 12 月至 2023 年 1 月期间,57 例接受三维(3D)打印辅助体外开窗(n = 32)或常规体外开窗(n = 25)治疗的 TBAD 患者的临床资料。比较两组患者的一般资料、手术时间、技术成功率、并发症发生率、二次干预率、死亡率和主动脉重塑情况。
与常规组相比,3D 打印辅助组手术时间明显缩短(147.84 ± 33.94 min 比 223.40 ± 65.93 min,p < 0.001),即刻内漏发生率明显降低(3.1%比 24%,p = 0.048),支架移植物段真腔直径扩张率明显增高(均 p < 0.05),但支架移植物修改时间明显延长(37.63 ± 2.99 min 比 28.4 ± 2.12 min,p < 0.001)。两组患者其他手术结果比较,差异均无统计学意义(p > 0.05)。两组支架移植物段的假腔血栓形成程度均高于非支架移植物段,差异有统计学意义(X2 = 5.390,4.878;p = 0.02,0.027)。
对于近端锚定区不理想的 TBAD,两种技术均安全有效。3D 打印辅助体外开窗 TEVAR 技术在手术时间、内漏风险和主动脉重塑方面具有优势,而传统体外开窗 TEVAR 技术在支架修改方面具有优势。